MedKoo Cat#: 525914 | Name: Periciazine
Featured

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Periciazine is a drug that belongs to the phenothiazine class of typical antipsychotics. Periciazine is used to treat short-term severe anxiety or tension and in the maintenance treatment of psychotic disorders such as schizophrenia.

Chemical Structure

Periciazine
CAS#2622-26-6

Theoretical Analysis

MedKoo Cat#: 525914

Name: Periciazine

CAS#: 2622-26-6

Chemical Formula: C21H23N3OS

Exact Mass: 365.1562

Molecular Weight: 365.50

Elemental Analysis: C, 69.01; H, 6.34; N, 11.50; O, 4.38; S, 8.77

Price and Availability

Size Price Availability Quantity
10mg USD 350.00 2 Weeks
25mg USD 550.00 2 Weeks
100mg USD 1,650.00 2 Weeks
Bulk Inquiry
Buy Now
Add to Cart
Related CAS #
No Data
Synonym
Periciazine; Periciazine; Periciazinum; RP 8908; RP 8909; SKF 20,716.
IUPAC/Chemical Name
10-(3-(4-Hydroxypiperidino)propyl)phenothiazine-2-carbonitrile
InChi Key
LUALIOATIOESLM-UHFFFAOYSA-N
InChi Code
InChI=1S/C21H23N3OS/c22-15-16-6-7-21-19(14-16)24(18-4-1-2-5-20(18)26-21)11-3-10-23-12-8-17(25)9-13-23/h1-2,4-7,14,17,25H,3,8-13H2
SMILES Code
c1ccc2c(c1)N(c3cc(ccc3S2)C#N)CCCN4CCC(CC4)O
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info
Product Data
Biological target:
Pericyazine is a selective D2-dopamine receptor antagonist.
In vitro activity:
TBD
In vivo activity:
TBD
Solvent mg/mL mM comments
Solubility
DMSO 127.5 348.84
Note: There can be variations in solubility for the same chemical from different vendors or different batches from the same vendor. The following factors can affect the solubility of the same chemical: solvent used for crystallization, residual solvent content, polymorphism, salt versus free form, degree of hydration, solvent temperature. Please use the solubility data as a reference only. Warming and sonication will facilitate dissolving. Still have questions? Please contact our Technical Support scientists.

Preparing Stock Solutions

The following data is based on the product molecular weight 365.50 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
TBD
In vitro protocol:
TBD
In vivo protocol:
TBD
1: Nakamura S, Masuda S, Oda S, Yamakawa D, Yamaguchi S, Ishima T, Kimura N, Aizawa K. Polypharmacy-related Shock Symptoms and Complications Associated with Phenothiazine. Intern Med. 2024 Jun 15;63(12):1829-1835. doi: 10.2169/internalmedicine.2012-23. Epub 2023 Nov 13. PMID: 37952960; PMCID: PMC11239264. 2: Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. Periciazine. 2023 Jan 16. PMID: 35442605. 3: Saito J, Tachibana Y, Wada YS, Yakuwa N, Kawasaki H, Suzuki T, Sago H, Yamatani A, Murashima A. Transfer of brotizolam, periciazine, and sulpiride in cord blood and breast milk, and alprazolam in breast milk: a case report. J Pharm Health Care Sci. 2022 Apr 1;8(1):10. doi: 10.1186/s40780-022-00241-2. PMID: 35361275; PMCID: PMC8973510. 4: Zakharova NM, Tarahovsky YS, Komelina NP, Khrenov MO, Kovtun AL. Pharmacological torpor prolongs rat survival in lethal normobaric hypoxia. J Therm Biol. 2021 May;98:102906. doi: 10.1016/j.jtherbio.2021.102906. Epub 2021 Mar 18. PMID: 34016333. 5: Zakharova NM, Tarahovsky YS, Komelina NP, Fadeeva IS, Kovtun AL. Long-term pharmacological torpor of rats with feedback-controlled drug administration. Life Sci Space Res (Amst). 2021 Feb;28:18-21. doi: 10.1016/j.lssr.2020.11.002. Epub 2020 Nov 26. PMID: 33612175. 6: Sokolova SV, Sozarukova MM, Khannanova AN, Grishina NK, Portnova GV, Proskurnina EV. Antioksidantnyi status pri paranoidnoi shizofrenii i bolezni Al'tsgeimera [Antioxidant status in patients with paranoid schizophrenia and Alzheimer disease]. Zh Nevrol Psikhiatr Im S S Korsakova. 2020;120(6):82-87. Russian. doi: 10.17116/jnevro202012006182. PMID: 32678552. 7: Gubbiotti M, Elisei S, Bedetti C, Marchiafava M, Giannantoni A. Urinary and bowel disfunction in autism spectrum disorder: a prospective, observational study. Psychiatr Danub. 2019 Sep;31(Suppl 3):475-478. PMID: 31488775. 8: Zakharova NM, Tarahovsky YS, Fadeeva IS, Komelina NP, Khrenov MO, Glushkova OV, Prokhorov DA, Kutyshenko VP, Kovtun AL. A pharmacological composition for induction of a reversible torpor-like state and hypothermia in rats. Life Sci. 2019 Feb 15;219:190-198. doi: 10.1016/j.lfs.2019.01.023. Epub 2019 Jan 16. PMID: 30658098. 9: Afandiyev I, Azizov V. [POISONING BY PSYCHOPHARMACOLOGICAL DRUGS IN AZERBAIJAN: THE RESULTS OF 8-YEAR PROSPECTIVE OBSERVATION]. Georgian Med News. 2017 Nov;(272):138-144. Russian. PMID: 29227273. 10: Danilov DS. Éffektivnost' i perenosimost' terapii peritsiazinom bol'nykh shizotipicheskim rasstroĭstvom, organicheskim rasstroĭstvom lichnosti i patsientov s patokharakterologicheskimi narusheniiami v ramkakh rasstroĭstv lichnosti [The efficacy and tolerability of pericyazine in the treatment of patients with schizotypal disorder, organic personality disorders and pathocharacterological changes within personality disorders]. Zh Nevrol Psikhiatr Im S S Korsakova. 2017;117(10):65-71. Russian. doi: 10.17116/jnevro201711710165-71. PMID: 29171491. 11: Juliano ACDSRS, Lucchetti ALG, Silva JTSD, Santos LG, Nunes JBT, Fernandes GC, Lucchetti G. Inappropriate Prescribing in Older Hospitalized Adults: A Comparison of Medical Specialties. J Am Geriatr Soc. 2018 Feb;66(2):383-388. doi: 10.1111/jgs.15138. Epub 2017 Oct 4. PMID: 28975608. 12: Danilov DS. Sovremennyĭ vzgliad na istoriiu atipichnykh antipsikhoticheskikh sredstv [A current view on the history of atypical antipsychotics]. Zh Nevrol Psikhiatr Im S S Korsakova. 2017;117(5):85-93. Russian. doi: 10.17116/jnevro20171175185-93. PMID: 28638038. 13: Cai HL, Deng Y, Fang PF, Cao S, Hou ZY, Wu YQ, Chen XJ, Yan M, Zhang B. A sensitive LC-MS/MS method for analysis of pericyazine in presence of 7-hydroxypericyazine and pericyazine sulphoxide in human plasma and its application to a comparative bioequivalence study in Chinese healthy volunteers. J Pharm Biomed Anal. 2017 Feb 20;135:67-74. doi: 10.1016/j.jpba.2016.12.007. Epub 2016 Dec 15. PMID: 28012307. 14: Matar HE, Almerie MQ, Makhoul S, Xia J, Humphreys P. Pericyazine for schizophrenia. Cochrane Database Syst Rev. 2014 May 13;2014(5):CD007479. doi: 10.1002/14651858.CD007479.pub2. PMID: 24825770; PMCID: PMC11023599. 15: Avgerinos D, Rabitnokov Y, Worku B, Neragi-Miandoab S, Girardi LN. Fifteen- year experience and outcomes of pericardiectomy for constrictive pericarditis. J Card Surg. 2014 Jul;29(4):434-8. doi: 10.1111/jocs.12344. Epub 2014 Apr 18. PMID: 24750218. 16: Futsukaichi K, Matsumoto K, Fujita K, Abe R, Noguchi T. [Severe hypotension and ventricular fibrillation during combined general and epidural anesthesia in a patient on major tranquilizers]. Masui. 2012 Oct;61(10):1121-4. Japanese. PMID: 23157101. 17: Ikeda H, Tsuji E, Matsubara T, Yukawa M, Fujisawa M, Yukawa E, Aki H. Incompatibility between propericiazine oral solution and tea-based drink. Chem Pharm Bull (Tokyo). 2012;60(9):1207-11. doi: 10.1248/cpb.c12-00116. PMID: 22976331. 18: Hong PS, Veasey RA, Sulke N. All is not lost: utilizing continuous remote ILR monitoring to diagnose syncope. Pacing Clin Electrophysiol. 2010 Jun 1;33(6):763-5. doi: 10.1111/j.1540-8159.2009.02662.x. Epub 2010 Feb 1. PMID: 20132509. 19: McGregor C, Srisurapanont M, Mitchell A, Wickes W, White JM. Symptoms and sleep patterns during inpatient treatment of methamphetamine withdrawal: a comparison of mirtazapine and modafinil with treatment as usual. J Subst Abuse Treat. 2008 Oct;35(3):334-42. doi: 10.1016/j.jsat.2007.12.003. Epub 2008 Mar 7. PMID: 18329221. 20: Kandagal PB, Kalanur SS, Manjunatha DH, Seetharamappa J. Mechanism of interaction between human serum albumin and N-alkyl phenothiazines studied using spectroscopic methods. J Pharm Biomed Anal. 2008 Jun 9;47(2):260-7. doi: 10.1016/j.jpba.2008.01.027. Epub 2008 Jan 20. PMID: 18313253.